We are live on ! Find out more
CGNT

Cogentix Medical, Inc.
CGNT

Delisted

CGNT was delisted on the 20th of April, 2018.

Back to rankings

44 hedge funds and large institutions have $27.9M invested in Cogentix Medical, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

36% more capital invested

Capital invested by funds: $20.6M → $27.9M (+$7.38M)

19% more funds holding

Funds holding: 37 → 44 (+7)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

Holders
44
Holders Change
+7
Holders Change %
+18.92%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
8
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WPC
White Pine Capital
Minnesota
+$493K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$460K
3
Renaissance Technologies
Renaissance Technologies
New York
+$230K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$86K
5
BCM
Bridgeway Capital Management
Texas
+$74.4K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$961K
2
VF
Virtu Financial
New York
-$121K
3
PCM
Perkins Capital Management
Minnesota
-$90.3K
4
ARTA
A.R.T. Advisors
New York
-$36K
5
Citadel Advisors
Citadel Advisors
Florida
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
AGM
26
Alpine Global Management
New York
$57K +$52.3K +18,150 New
State Street
27
State Street
Massachusetts
$48K +$42.9K +14,897 New
GC
28
Guggenheim Capital
Illinois
$46K -$7.27K -2,524 -15%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$46K – – –
BBHC
30
Brown Brothers Harriman & Co
New York
$44K – – –
Stifel Financial
31
Stifel Financial
Missouri
$34K +$31.1K +10,786 New
Barclays
32
Barclays
United Kingdom
$33K +$30K +10,400 New
SC
33
Searle & Co
Connecticut
$32K – – –
JP Morgan Chase
34
JP Morgan Chase
New York
$17K +$865 +300 +6%
FWM
35
Focused Wealth Management
New York
$11K – – –
AF
36
Advisornet Financial
Minnesota
$11K +$10K +3,474 New
TDC
37
Thompson Davis & Co
Virginia
$9K -$5.76K -2,000 -40%
US Bancorp
38
US Bancorp
Minnesota
$9K – – –
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$8K +$7.45K +2,584 New
Morgan Stanley
40
Morgan Stanley
New York
$6K – – –
AG
41
Advisor Group
Arizona
$5K – – –
IA
42
IFP Advisors
Florida
$4K +$4.09K +1,418 New
TRCT
43
Tower Research Capital (TRC)
New York
$3K +$2.92K +1,014 New
Bank of America
44
Bank of America
North Carolina
$2K -$173 -60 -8%
Federated Hermes
45
Federated Hermes
Pennsylvania
$1K +$1.26K +438 New
VF
46
Virtu Financial
New York
– -$121K -47,294 Closed
ARTA
47
A.R.T. Advisors
New York
– -$36K -14,412 Closed
Citadel Advisors
48
Citadel Advisors
Florida
– -$29K -11,197 Closed
UBS Group
49
UBS Group
Switzerland
– -$6K -2,427 Closed
1
2

CGNT Hedge Fund Activity: Q4 2017 in Review

44 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cogentix Medical, Inc. (CGNT) for Q4 2017, worth a combined $27.9M — up 36% from $20.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CGNT positions and 5 closed out — a net gain of 7 holders — while 8 added to existing stakes and 10 trimmed.

The largest buyer was White Pine Capital, adding an estimated $493K. The largest seller was Broadfin Capital, cutting an estimated $961K.

  • 44 institutional investors held Cogentix Medical, Inc. (CGNT) as of Q4 2017, up from 37 in Q3 2017.
  • Funds reported $27.9M of Cogentix Medical, Inc. stock for Q4 2017, up 36% quarter-over-quarter.
  • 12 funds opened new Cogentix Medical, Inc. positions in Q4 2017 and 5 closed out, a net change of +7 holders.
  • The largest Cogentix Medical, Inc. buyer in Q4 2017 was White Pine Capital, an estimated $493K added.
  • The largest Cogentix Medical, Inc. seller in Q4 2017 was Broadfin Capital, an estimated $961K sold.

Based on aggregated 13F filings for Q4 2017.